{"organizations": [], "uuid": "297ae8fc5b0b73d58179bcdf96af29c68f7ed90c", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 1, "shares": 1, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180201.html", "section_title": "Archive News &amp; Video for Thursday, 01 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/novo-nordisk-results-ceo/novo-nordisk-ceo-welcomes-amazon-berkshire-jpmorgan-pharma-company-idUSC7N1O701E", "country": "US", "domain_rank": 408, "title": "Novo Nordisk CEO welcomes Amazon, Berkshire, JPMorgan pharma company", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-01T19:22:00.000+02:00", "replies_count": 0, "uuid": "297ae8fc5b0b73d58179bcdf96af29c68f7ed90c"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/novo-nordisk-results-ceo/novo-nordisk-ceo-welcomes-amazon-berkshire-jpmorgan-pharma-company-idUSC7N1O701E", "ord_in_thread": 0, "title": "Novo Nordisk CEO welcomes Amazon, Berkshire, JPMorgan pharma company", "locations": [], "entities": {"persons": [{"name": "berkshire", "sentiment": "negative"}, {"name": "teis jensen", "sentiment": "none"}, {"name": "jason neely", "sentiment": "none"}, {"name": "jacob gronholt-pedersen", "sentiment": "none"}, {"name": "lars fruergaard jorgensen", "sentiment": "none"}], "locations": [{"name": "copenhagen", "sentiment": "none"}, {"name": "united states", "sentiment": "none"}], "organizations": [{"name": "berkshire", "sentiment": "negative"}, {"name": "amazon", "sentiment": "negative"}, {"name": "feb", "sentiment": "negative"}, {"name": "jpmorgan", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "amazon.com inc", "sentiment": "negative"}, {"name": "novo nordisk", "sentiment": "negative"}, {"name": "hathaway inc", "sentiment": "none"}, {"name": "jpmorgan chase & co", "sentiment": "none"}, {"name": "pharmacy benefit managers", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "COPENHAGEN, Feb 1 (Reuters) - Novo Nordisk’s chief executive welcomes that Amazon.com Inc, Berkshire Hathaway Inc and JPMorgan Chase & Co, has established a new company to cut health costs for their employees.\nLars Fruergaard Jorgensen said on Thursday that the three companies, which presented the new company on Wednesday, and Novo Nordisk would have “well-aligned objectives”.\n“This creates an opportunity for us to better position our products in the United States,” he told investors after the company’s full-year report.\nPrice pressure on Novo Nordisk in the United States is in part due to consolidation among so-called Pharmacy Benefit Managers who administer drug benefits for employers and health plans. (Reporting by Jacob Gronholt-Pedersen, writing by Teis Jensen; editing by Jason Neely)\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-01T19:22:00.000+02:00", "crawled": "2018-02-02T13:01:32.011+02:00", "highlightTitle": ""}